Angiodynamics Inc ANGO

$15.55 +0.44 (2.91%)

Valuation

Market cap
635,436,000
Revenue TTM
$320,170,000
Net income TTM
$-36,740,000
PE ratio
0.00
Forward PE
—
Profit margin
-11.48%
Debt to equity
0.00

Trading

Volume
181,941
Avg volume
462,662
Day's range
$14.92 – $15.62
Shares out
42,054,000
Stochastic %K
22%
Beta
0.30
Analysts
Strong Sell
Price target
$18.60

Price

Company profile

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. T...

Show more

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which include angiographic catheters, guidewires, drainage catheters, and micropuncture kits for use in invasive procedures. In addition, the company provides total abscession drainage catheters for multi-purpose/general and biliary configurations, and nephrostomy options; mini stick MAX Coaxial microintroducer kits and micro-introducer kits; ports; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Industry
Medical Instruments & Supplies
Sector
Healthcare
Phone
518 795 1400
Website
https://www.angiodynamics.com
Address
14 Plaza Drive, Latham, United States

Latest news

Stocktwits

prismmarketview Oct 2, 1:46 PM
$ANGO + The PERT Consortium name Jacobi Hospital (Bronx) an ALPHA-PE Research Fund award recipient. Investigator-led study (Dr. Jonathan Alis, Dr. Seth Sokol) will test whether CT pulmonary angiography radiomics can predict thrombus biology, thrombectomy success, and long-term PE outcomes. ALPHA-PE program: investigator-driven, grants $50K-$750K over 1-3 years, run jointly with PERT Consortium to close PE evidence gaps. No results yet, this funds future research, it isn't a clinical readout. Supports ANGO's positioning in its vascular/PE care franchise. $ANGO #MedTech #ClinicalResearch https://prismmarketview.com/angiodynamics-backs-jacobi-hospital-study-to-predict-pulmonary-embolism-thrombectomy-success/
0 replies
SuperCoach Sep 30, 3:42 PM
$ANGO Interview w/CEO Jim Clemmer . . . https://www.investmentreports.co/interview/jim-clemmer-2618
0 replies
SuperCoach Sep 25, 12:11 AM
$ANGO Dr. Stuart Collins has now performed his 100th NanoKnife procedure for localized prostate cancer at Noosa Hospital in Queensland, Australia — another notable milestone for NanoKnife adoption. 🌏 https://noosatoday.com.au/news/23-09-2026/milestone-reached-in-prostate-care/
0 replies
SuperCoach Sep 19, 1:09 AM
$ANGO Cromwell Hospital in London reported completing its first NanoKnife prostate procedure, led by focal-therapy specialist Professor Hashim Ahmed . . . https://www.linkedin.com/posts/cromwellhospital_earlier-this-week-our-theatre-team-marked-activity-7506740111984844800-2_q0
0 replies
SuperCoach Sep 19, 1:07 AM
$ANGO ARTICLE EXCERPT: The NanoKnife System is the only function-preserving procedure that uses electricity to eliminate cancer cells. “This system is designed to precisely treat small prostate cancer tumors, removing the need for radical prostate surgery or major radiation,” said Dr. Cangiano. 👇🏻READ FULL ARTICLE HERE👇🏻 https://www.adventhealth.com/blogs/nanoknife-system-revolutionizing-prostate-cancer-care
0 replies
NVDAMillionaire Sep 14, 5:53 PM
$ANGO Really good write-up that perfectly summarizes ANGO's present situation. So if you want to bring your ANGO knowledge up to date or just discover ANGO, this is required reading. https://everyticker.com/quote/ANGO/analysis/angiodynamics-med-tech-metamorphosis-a-niche-specialist-s-fragile-path-to-profitability-nasdaq-ango
0 replies
N8LongShort Jul 31, 2:48 PM
$ANGO expecting more payers to be available
0 replies
ToadEsquireCapital Jul 30, 4:34 AM
$ANGO i see these products used on a regular basis. Superior to competitive products. Cheap at these prices. Will be 2-3x or acquired by 2030. 🔮
1 replies